Results 41 to 50 of about 16,859 (216)

Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease.

open access: yesJAMA Neurology, 2019
Importance Fluid biomarkers that can predict survival time in sporadic Creutzfeldt-Jakob disease (sCJD) will be critical for clinical care and for treatment trials.
A. Staffaroni   +15 more
semanticscholar   +1 more source

Subtype Diagnosis of Sporadic Creutzfeldt–Jakob Disease with Diffusion Magnetic Resonance Imaging

open access: yesAnnals of Neurology, 2020
Sporadic Creutzfeldt–Jakob disease (sCJD) comprises several subtypes as defined by genetic and prion protein characteristics, which are associated with distinct clinical and pathological phenotypes.
A. Bizzi   +12 more
semanticscholar   +1 more source

Sporadic Creutzfeldt-Jakob disease prion infection of human cerebral organoids

open access: yesActa Neuropathologica Communications, 2019
For the transmissible, neurogenerative family of prion diseases, few human models of infection exist and none represent structured neuronal tissue. Human cerebral organoids are self-organizing, three-dimensional brain tissues that can be grown from ...
B. Groveman   +6 more
semanticscholar   +1 more source

Public health concerns regarding sporadic Creutzfeldt–Jakob disease in China: a case series

open access: yesJournal of International Medical Research, 2019
In this study, we report three cases of sporadic Creutzfeldt–Jakob disease in China, two confirmed cases and one probable case. The aim of this study was to enrich the data regarding clinical and epidemiological features of this disease and to provide ...
Ru-Yi Zhou   +12 more
doaj   +1 more source

Detection of Infectivity in Blood of Persons with Variant and Sporadic Creutzfeldt-Jakob Disease

open access: yesEmerging Infectious Diseases, 2014
We report the presence of infectivity in erythrocytes, leukocytes, and plasma of 1 person with variant Creutzfeldt-Jakob disease and in the plasma of 2 in 4 persons whose tests were positive for sporadic Creutzfeldt-Jakob disease.
Jean Yves Douet   +11 more
doaj   +1 more source

A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease

open access: yesAlzheimer's & Dementia, 2020
We developed a prognostic model for overall survival after diagnosis of sporadic Creutzfeldt‐Jakob disease (sCJD) using data from a German surveillance study.
F. Llorens   +7 more
semanticscholar   +1 more source

Young-onset sporadic Creutzfeldt–Jakob disease with atypical phenotypic features: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Sporadic Creutzfeldt–Jakob disease, with a mean survival of 6 months, is duly considered among the most fatal neurological disorders. Rapidly progressive dementia with multi-axial involvement of the nervous system is the known presentation ...
Durjoy Lahiri   +5 more
doaj   +1 more source

Sporadic Creutzfeldt–Jakob disease

open access: yes, 2018
Sporadic Creutzfeldt-Jakob disease (CJD), the most common human prion disease, is generally regarded as a spontaneous neurodegenerative illness, arising either from a spontaneous PRNP somatic mutation or a stochastic PrP structural change. Alternatively, the possibility of an infection from animals or other source remains to be completely ruled out ...
Zerr, Inga, Parchi, Piero
openaire   +4 more sources

Rapidly Progressive Probable Sporadic Creutzfeldt-Jakob Disease

open access: yesCureus, 2022
Creutzfeldt-Jakob disease (CJD) is a rare, fatal brain infection caused by a human prion. Because CJD is associated with rapidly progressive neurological degeneration, it requires high suspicion for diagnosis. We report the case of a 79-year-old patient who presented with a rapidly progressive neurological clinical picture.
Elziny, Moustafa M, Elsaid, Shaimaa S
openaire   +2 more sources

Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression

open access: yesJournal of Neurology Neurosurgery & Psychiatry, 2018
Objectives A blood-based biomarker of neuronal damage in sporadic Creutzfeldt-Jakob disease (sCJD) will be extremely valuable for both clinical practice and research aiming to develop effective therapies.
A. Thompson   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy